» Articles » PMID: 37140811

Signaling Pathways in Trans-differentiation of Mesenchymal Stem Cells: Recent Advances

Overview
Specialty Molecular Biology
Date 2023 May 4
PMID 37140811
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells are a group of multipotent cells that can be induced to differentiate into other cell types. The cells fate is decided by various signaling pathways, growth factors, and transcription factors in differentiation. The proper coordination of these factors will result in cell specification. MSCs are capable of being differentiated into osteogenic, chondrogenic, and adipogenic lineages. Different conditions induces the MSCs into particular phenotypes. The MSC trans-differentiation ensues as a response to environmental factors or due to circumstances that prove to favor trans-differentiation. Depending on the stage at which they are expressed, and the genetic alterations they undergo prior to their expression, transcription factors can accelerate the process of trans-differentiation. Further research has been conducted on the challenging aspect of MSCs being developed into non-mesenchymal lineage. The cells that are differentiated in this way maintain their stability even after being induced in animals. The recent advancements in the trans-differentiation capacities of MSCs on induction with chemicals, growth inducers, improved differentiation mediums, growth factors from plant extracts, and electrical stimulation are discussed in this paper. Signaling pathways have a great effect on MSCs trans-differentiation and they need to be better understood for their applications in therapeutic techniques. So, this paper tends to review the major signaling pathways that play a vital role in the trans-differentiation of MSC.

Citing Articles

The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice.

Sun J, Luo D, Li H, Zhang D, Liu Y, Jin S Can Respir J. 2024; 2024:8827810.

PMID: 39735556 PMC: 11671638. DOI: 10.1155/carj/8827810.

References
1.
Sellheyer K, Krahl D . Cutaneous mesenchymal stem cells: status of current knowledge, implications for dermatopathology. J Cutan Pathol. 2009; 37(6):624-34. DOI: 10.1111/j.1600-0560.2009.01477.x. View

2.
Almalki S, Agrawal D . Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016; 92(1-2):41-51. PMC: 5010472. DOI: 10.1016/j.diff.2016.02.005. View

3.
Sriramulu S, Banerjee A, Di Liddo R, Jothimani G, Gopinath M, Murugesan R . Concise Review on Clinical Applications of Conditioned Medium Derived from Human Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs). Int J Hematol Oncol Stem Cell Res. 2019; 12(3):230-234. PMC: 6305261. View

4.
Schilling T, Noth U, Klein-Hitpass L, Jakob F, Schutze N . Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol. 2007; 271(1-2):1-17. DOI: 10.1016/j.mce.2007.03.004. View

5.
Schilling T, Kuffner R, Klein-Hitpass L, Zimmer R, Jakob F, Schutze N . Microarray analyses of transdifferentiated mesenchymal stem cells. J Cell Biochem. 2007; 103(2):413-33. DOI: 10.1002/jcb.21415. View